Tevogen Inc. TVGN
7.25
(0.60)
(7.64%)
as of 25 Sep
- Market cap
- $51.1M
- P/E
- 0.0×
Follow TVGN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
0.33 | 0.29 | 0.22 | 0.31 |
+8 more quarters Free account |
Net Debt/EBITDA |
(0.95) | (1.07) | (0.85) | (0.59) | |
Debt/Assets |
135.37% | 130.05% | 100.39% | 97.91% | |
Debt/Equity |
(0.72) | (0.65) | (0.53) | (0.56) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.51 | 0.49 | 0.44 | 0.64 | |
Capex/Depreciation |
0.00 | 0.00 | (0.75) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.78) | (0.78) | (0.68) | (0.93) | |
Cash per Share |
0.28 | 0.20 | 0.17 | 0.26 | |
Shareholders Equity per Share |
(2.32) | (2.82) | (2.48) | (2.00) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.32) | (2.82) | (2.48) | (2.00) | |
Free Cash Flow |
(3.01) | (2.73) | (2.25) | (3.65) | |
Working Capital |
(4.14) | (5.13) | (5.53) | (4.62) | |
Capital Expenditures |
— | — | (0.06) | — | |
Net Current Asset Value |
(11.61) | (12.62) | (11.08) | (10.20) | |
| Other line items | |||||
Quick Ratio |
0.20 | 0.12 | 0.10 | 0.18 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.78) | (0.78) | (0.66) | (0.93) | |
Capex per Share |
0.00 | 0.00 | (0.02) | 0.00 | |
Average Receivables |
0.16 | 0.16 | 0.16 | 0.16 | |
Average Payables |
3.53 | 4.23 | 4.27 | 4.58 | |
Average Assets |
4.50 | 4.50 | 3.92 | 4.39 | |
Average Common Equity |
(17.99) | (17.58) | (16.25) | (14.81) | |
Capex to Sales |
— | — | 0.00 | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates